Early menopause appears raise odds of breast cancer, study reports

by Dennis Thompson.Women who underwent menopause at an age younger than 46 were nearly twice as likely to havebreast cancercompared to others their age, researchers found.The study, appear

Updated on: August 27,2024 0

Early menopause appears raise odds of breast cancer, study reports

by Dennis Thompson.Women who underwent menopause at an age younger than 46 were nearly twice as likely to havebreast cancercompared to others their age, researchers found.The study, appear

Updated on:August 27,2024 0

Study finds fluorescent guide can help detect tumor left behind after breast cancer surgery

by Mass General BrighamMargin Scoring Schema.Pegulicianine fluorescence-guided surgery (pFGS) readings (positive or negative) from each lumpectomy cavity orientation were compared with hist

Updated on: February 23,2024 19

Study finds fluorescent guide can help detect tumor left behind after breast cancer surgery

by Mass General BrighamMargin Scoring Schema.Pegulicianine fluorescence-guided surgery (pFGS) readings (positive or negative) from each lumpectomy cavity orientation were compared with hist

Updated on:February 23,2024 19

New insight into aggressive breast cancers

by Cardiff UniversityCredit: CC0 Public DomainScientists from Cardiff University have uncovered a protein which drives aggressive breast cancer and could be targeted for developing new and improv

Updated on: March 06,2024 14

New insight into aggressive breast cancers

by Cardiff UniversityCredit: CC0 Public DomainScientists from Cardiff University have uncovered a protein which drives aggressive breast cancer and could be targeted for developing new and improv

Updated on:March 06,2024 14

Incidence of cutaneous T-cell lymphoma up in the U.S.

The overall incidence of cutaneous T-cell lymphoma (CTCL) increased in the United States from 2000 to 2018, according to a research letter published online Sept. 1 inJAMA Oncology.Zhuo Ran Cai,

Updated on: January 02,2024 10

Incidence of cutaneous T-cell lymphoma up in the U.S.

The overall incidence of cutaneous T-cell lymphoma (CTCL) increased in the United States from 2000 to 2018, according to a research letter published online Sept. 1 inJAMA Oncology.Zhuo Ran Cai,

Updated on:January 02,2024 10

New approach to shutting down breast cancer recurrence shows promise in mice

by Sarah Avery,Duke UniversityGraphical Abstract. Credit:Cell Reports(2019). DOI: 10.1016/j.celrep.2019.09.032A new approach to treat advanced breast cancer shuts down the growth of

Updated on: March 12,2024 13

New approach to shutting down breast cancer recurrence shows promise in mice

by Sarah Avery,Duke UniversityGraphical Abstract. Credit:Cell Reports(2019). DOI: 10.1016/j.celrep.2019.09.032A new approach to treat advanced breast cancer shuts down the growth of

Updated on:March 12,2024 13

FDA approves first CAR T-cell therapy for adults with leukemia or lymphoma

by Lori SolomonThe U.S. Food and Drug Administration has approved Bristol Myers Squibb's Breyanzi (lisocabtagene maraleucel [liso-cel]) as the first CD19-directed chimeric antigen receptor (CAR) T

Updated on: March 30,2024 0

FDA approves first CAR T-cell therapy for adults with leukemia or lymphoma

by Lori SolomonThe U.S. Food and Drug Administration has approved Bristol Myers Squibb's Breyanzi (lisocabtagene maraleucel [liso-cel]) as the first CD19-directed chimeric antigen receptor (CAR) T

Updated on:March 30,2024 0

Breast cancer patients can safely avoid extensive removal of lymph nodes if they respond well to systemic treatment

by European Organisation for Research and Treatment of CancerCredit: Pixabay/CC0 Public DomainPatients with breast cancer that has started to spread to the lymph nodes in the armpit can safely avoid e

Updated on: March 30,2024 0

Breast cancer patients can safely avoid extensive removal of lymph nodes if they respond well to systemic treatment

by European Organisation for Research and Treatment of CancerCredit: Pixabay/CC0 Public DomainPatients with breast cancer that has started to spread to the lymph nodes in the armpit can safely avoid e

Updated on:March 30,2024 0

Immunotherapy comparable to chemo for some advanced stomach cancers

by Cancer Research UKCredit: CC0 Public DomainAn immunotherapy drug could prove just as effective as chemotherapy in prolonging the lives of patients with advanced cancers of the stomach or food

Updated on: May 21,2024 6

Immunotherapy comparable to chemo for some advanced stomach cancers

by Cancer Research UKCredit: CC0 Public DomainAn immunotherapy drug could prove just as effective as chemotherapy in prolonging the lives of patients with advanced cancers of the stomach or food

Updated on:May 21,2024 6

Targeting ABC transporters in pancreatic ductal carcinoma—past, present, or future?

by Impact Journals LLCRole for ABCB1 in PDAC chemoresistance. Credit:Oncotarget(2024). DOI: 10.18632/oncotarget.28597A new editorial paper titled "Targeting ABC transporters in PDAC—p

Updated on: July 11,2024 0

Targeting ABC transporters in pancreatic ductal carcinoma—past, present, or future?

by Impact Journals LLCRole for ABCB1 in PDAC chemoresistance. Credit:Oncotarget(2024). DOI: 10.18632/oncotarget.28597A new editorial paper titled "Targeting ABC transporters in PDAC—p

Updated on:July 11,2024 0

Genetic causes of tumors in salivary glands

by University of Erlangen-NurembergCredit: CC0 Public DomainAcinic cell carcinoma is the third most common malignant form of salivary gland cancer. These tumours are similar to normal salivary gl

Updated on: March 09,2024 16

Genetic causes of tumors in salivary glands

by University of Erlangen-NurembergCredit: CC0 Public DomainAcinic cell carcinoma is the third most common malignant form of salivary gland cancer. These tumours are similar to normal salivary gl

Updated on:March 09,2024 16

Novel T cell receptor therapy shows early anti-tumor activity

byUniversity of Texas M. D. Anderson Cancer CenterCredit: CC0 Public DomainAfamitresgene autoleucel (afami-cel; formerly ADP-A2M4), an adoptive T cell receptor (TCR) therapy targeting the MAGE-A

Updated on: January 15,2024 20

Novel T cell receptor therapy shows early anti-tumor activity

byUniversity of Texas M. D. Anderson Cancer CenterCredit: CC0 Public DomainAfamitresgene autoleucel (afami-cel; formerly ADP-A2M4), an adoptive T cell receptor (TCR) therapy targeting the MAGE-A

Updated on:January 15,2024 20

'Dual-target' cell therapy appears to shrink brain tumors, research finds

by Perelman School of Medicine at the University of PennsylvaniaCredit: Anna Shvets from PexelsTargeting two brain tumor-associated proteins—rather than one—with CAR T cell therapy shows promise

Updated on: March 20,2024 19

'Dual-target' cell therapy appears to shrink brain tumors, research finds

by Perelman School of Medicine at the University of PennsylvaniaCredit: Anna Shvets from PexelsTargeting two brain tumor-associated proteins—rather than one—with CAR T cell therapy shows promise

Updated on:March 20,2024 19